<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01861041</url>
  </required_header>
  <id_info>
    <org_study_id>PROSTAT</org_study_id>
    <nct_id>NCT01861041</nct_id>
  </id_info>
  <brief_title>Low Dose Bupivacaine Spinal for Trans Uretral Prostatectomy.</brief_title>
  <acronym>TURP</acronym>
  <official_title>Low Dose, Low Concentration Different Baricity Bupivacaine for Transuretral Prostatectomy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Diskapi Yildirim Beyazit Education and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Diskapi Yildirim Beyazit Education and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Spinal anesthesia, is used during the transuretheral resection of the prostate.Low dose
      hyperbaric local anesthetics have been used to enhance the resolution of the spinal block. We
      compared the efficacy and duration of the spinal block with two different bupivacaine
      baricities.

        -  Group I: low dose isobaric group

        -  GroupII: Low dose hyperbaric group
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients undergoing TURP were randomly allocated into two groups.

        -  Group I: Received fentanyl 20 µgr (0.4ml),heavy bupivacaine 0.5% (1.5 ml)and normal
           saline % 0.9 NaCl ( 1.1ml)

        -  Group II: Received fentanyl 20 µgr (0.4 ml), plain bupivacaine 0.5%(1.5 ml) normal
           saline 0.9% NaCl (1.1 mL) in total bupivacaine 0.25% (3ml) intrathecally.

      Onset and duration of the sensory block, the degree of the motor block, side - effects and
      perioperative analgesic requirement assesed.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">July 2013</completion_date>
  <primary_completion_date type="Anticipated">July 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Spinal Block Quality</measure>
    <time_frame>15 minute after intrathecal injection</time_frame>
    <description>Sensory block assesment with pinpric test.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Spinal block regression</measure>
    <time_frame>5 minute after arrival at PACU</time_frame>
    <description>Sensory block assesment with pinprick test</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">52</enrollment>
  <condition>Benign Prostate Hyperplasia</condition>
  <arm_group>
    <arm_group_label>Heavy Bupivacain, Local anesthetic, Amp</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Heavy bupivacaine 7.5 mg (1.5 ml), 20 microgram fentanyl(0.4 ml), 1.1 ml saline , Total 3 ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Isobaric spinal, Local anesthetic, Amp</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>7,5 mg isobaric bupivacaine, 20 microgram (0.4 ml)fentanyl, 1.1 ml saline, Total 3 ml</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Heavy Bupivacaine</intervention_name>
    <description>7,5 mg intrathecal hyperbaric bupivacain,</description>
    <arm_group_label>Heavy Bupivacain, Local anesthetic, Amp</arm_group_label>
    <other_name>marcaine heavy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Isobaric Bupivacaine</intervention_name>
    <description>7.5 mg intratecal isobaric bupivacain</description>
    <arm_group_label>Isobaric spinal, Local anesthetic, Amp</arm_group_label>
    <other_name>Marcain flakon</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  50-85 years ASA 1-4 BENİGN PROSTAT HYPERPLASİ

        Exclusion Criteria:

          -  Allergy of study drugs

          -  Morbid obesity

          -  Spinal anesthesia contrindications

          -  Bleeding dyscrasias
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>MURAT M SAYIN, Ass. Prof</last_name>
    <role>Study Director</role>
    <affiliation>Dispapi yildirim beyazit E R hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Diskapi Yildirim Beyazit Education and Research Hospital</name>
      <address>
        <city>Ankara</city>
        <zip>06610</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Murat M Sayin, Ass. Prof</last_name>
      <phone>+903125962580</phone>
      <email>muratsayin@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Reyhan POLAT, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Loubert C, Hallworth S, Fernando R, Columb M, Patel N, Sarang K, Sodhi V. Does the baricity of bupivacaine influence intrathecal spread in the prolonged sitting position before elective cesarean delivery? A prospective randomized controlled study. Anesth Analg. 2011 Oct;113(4):811-7. doi: 10.1213/ANE.0b013e3182288bf2. Epub 2011 Sep 2.</citation>
    <PMID>21890887</PMID>
  </reference>
  <reference>
    <citation>Kim SY, Cho JE, Hong JY, Koo BN, Kim JM, Kil HK. Comparison of intrathecal fentanyl and sufentanil in low-dose dilute bupivacaine spinal anaesthesia for transurethral prostatectomy. Br J Anaesth. 2009 Nov;103(5):750-4. doi: 10.1093/bja/aep263. Epub 2009 Sep 28.</citation>
    <PMID>19797249</PMID>
  </reference>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 15, 2013</study_first_submitted>
  <study_first_submitted_qc>May 21, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 23, 2013</study_first_posted>
  <last_update_submitted>May 21, 2013</last_update_submitted>
  <last_update_submitted_qc>May 21, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 23, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Diskapi Yildirim Beyazit Education and Research Hospital</investigator_affiliation>
    <investigator_full_name>Reyhan Polat</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>low dose</keyword>
  <keyword>different baricity</keyword>
  <keyword>spinal anesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperplasia</mesh_term>
    <mesh_term>Prostatic Hyperplasia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

